KIM A CONWAY

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Adult Health PARMA, OH NPI 1649536699

General Payments — all program years on this page

$648.28

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 27
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $401.84 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $401.8418

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Neurocrine BioSciences, Inc. $168.4315
Janssen Pharmaceuticals, Inc $148.681
Teva Pharmaceuticals USA, Inc. $84.732

By program year

Program yearAmountRecords
2021 $23.301
2022 $37.652
2023 $185.496
2024 $401.8418

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078136549 Janssen Pharmaceuticals, Inc $148.68 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151000734 Neurocrine Biosciences, Inc. $15.77 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151001370 Neurocrine Biosciences, Inc. $15.62 07/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151001736 Neurocrine Biosciences, Inc. $15.54 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151002270 Neurocrine Biosciences, Inc. $15.37 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151009247 Neurocrine Biosciences, Inc. $13.48 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151010611 Neurocrine Biosciences, Inc. $13.11 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151010905 Neurocrine Biosciences, Inc. $12.99 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151011089 Neurocrine Biosciences, Inc. $12.81 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151013594 Neurocrine Biosciences, Inc. $11.00 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151013616 Neurocrine Biosciences, Inc. $10.99 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151015471 Neurocrine Biosciences, Inc. $9.49 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151016975 Neurocrine Biosciences, Inc. $8.34 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151023100 Neurocrine Biosciences, Inc. $5.33 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151024457 Neurocrine Biosciences, Inc. $4.34 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151024593 Neurocrine Biosciences, Inc. $4.25 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151574371 Teva Pharmaceuticals USA, Inc. $65.75 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151574449 Teva Pharmaceuticals USA, Inc. $18.98 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.